Navigation Links
Topoisomerase in Medical News
CSHL scientists correlate enzyme expression levels with chemotherapy drug response
... or short-circuit this process." Regulating topoisomerase through gene "knockdown" The premise of the ... the expression of genes involved in producing topoisomerase enzymes. Four shRNAs were identified that ... Top2A, which codes for production of a particular topoisomerase ...... as a site-selective DNA intercalator and topoisomerase poison with selectivity for proliferating cells. ... and may have advantages over other topoisomerase poisons," said Daniel C. Adelman, M.D., Senior ... in indications such as breast cancer where topoisomerase II poisons are active." Sunesis researchers ...
DNA with a twist: New company to search for cancer drugs and antibiotics
... enable drug-discovery work in this area including topoisomerase enzymes themselves as well as associated ... on the standard gel-based screening method for topoisomerase inhibitors. Inspiralis Ltd will develop the ... rapidly divide in an uncontrolled manner and topoisomerase inhibitors can block this uncontrolled cell ...Sunesis Reports Financial Results for the First Quarter 2009
... clinical use for the treatment of breast cancer, including cisplatin and topoisomerase II inhibitors doxorubicin and etoposide. Data also established an enhanced ... for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 ...... a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA damage, was administered on a weekly or twice ... a first-in-class naphthyridine analog that intercalates DNA and poisons topoisomerase II causing selective DNA damage, is currently in a Phase 1b clinical trial ...
... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...
Gene alterations associated with response to anthracycline therapy for breast cancer
... Alterations in the topoisomerase II alpha ( TOP2A ) gene were associated with better patient outcomes following anthracycline-based therapy compared with non-anthracycline-based ...Biomarkers: What can they tell us
... M.D., Ph.D. Chemotherapy treatment selection based on biomarkers may not yet be a valuable practice. Prior studies have suggested that HER2 and topoisomerase II (TOP2A) might predict sensitivity to particular chemotherapy agents. An interim analysis shows that HER2 and TOP2A have a clinically modest and ...Class of Chemotherapy Drugs Helps Certain Breast Cancer Patients
... should get anthracyclines based just on HER2 status. That's because other research has suggested that the overexpression of another gene called topoisomerase II alpha (or topo2) may also play a role in how well anthracyclines work. "The topo2 gene is thought to be the real target of the anthracyclines," ...First look at an enzyme target for antibacterial and cancer drugs
... (Berkeley Lab) and the University of California (UC) at Berkeley have produced the first three-dimensional structural images of a DNA-bound Type II topoisomerase (topo II) that is responsible for untangling coiled strands of the chromosome during cell division. Preventing topo II from disentangling a cells ...Topoisomerase in Medical Technology
... anthracyclines and the rational design modifications to the chemical compound believed to be responsible for enhanced DNA damage and binding to topoisomerase II enzyme, a key target for anthracycline mediated tumor death. These modifications are also hypothesized by the authors to underlie the drugs' low ...
... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...
... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. In addition to the ongoing Phase 2 ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and rapid apoptosis. The topoisomerase II-associated DNA ...
... an increase in SN38 exposure that was up to six-fold higher than the exposure previously reported with irinotecan at equivalent doses. SN38, a topoisomerase I inhibitor, is the active metabolite of irinotecan. The ASCO abstract reports interim data on 27 of 32 patients in the first of three dose ...
... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...
Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH
... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated as a ...... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...
Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication- dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being ...... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. In addition to the ongoing Phase 2 ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and rapid apoptosis. Voreloxin is currently being evaluated ...
... to quinolones, a class of compounds which has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site- selective DNA damage, irreversible G2 arrest and rapid apoptosis. The topoisomerase II-associated DNA ...
... an increase in SN38 exposure that was up to six-fold higher than the exposure previously reported with irinotecan at equivalent doses. SN38, a topoisomerase I inhibitor, is the active metabolite of irinotecan. The ASCO abstract reports interim data on 27 of 32 patients in the first of three dose ...
Topoisomerase in Medical Dictionary
... excess fluid in body tissue s. edotecarin A substance that is being studied in the treatment of cancer . It belongs to the family of drugs called topoisomerase I inhibitors. Also called J-107088. Swelling of the eyelids and tissue s around the eyes , especially in the morning. Swelling of the ...
... such as a specific food . A drug used to treat a variety of childhood cancer s. Epipodophyllo toxins belong to a larger class of drugs called topoisomerase II inhibitors. epirubicin ... Radiation Sunlight Tobacco Certain virus es Benzene Certain poison ous mushrooms and afla toxins (a poison ...
... such as a specific food . A drug used to treat a variety of childhood cancer s. Epipodophyllo toxins belong to a larger class of drugs called topoisomerase II inhibitors. epirubicin ... Radiation Sunlight Tobacco Certain virus es Benzene Certain poison ous mushrooms and afla toxins (a poison ...
Topoisomerase in Biological News
... general readership," wrote Wang. The book will appeal to those with a general interest in molecular biology, the biological and clinical aspects of topoisomerase function, or in the mathematics and physics of topology.
Wang starts with the history of the "insuperable" DNA entanglement problem and describes ...
... featured on the cover of this issue. The enzyme topoisomerase IB releases the torsion built up in DNA strands. ... time as it acted on a single DNA molecule. The topoisomerase clamps onto the DNA, cuts through one of the two ... and under certain conditions even stop it. topoisomerase IB can reduce these torsional forces. The ...
CTRC-AACR San Antonio Breast Cancer Symposium
... small HER2-positive tumors Evaluation of letrozole as adjuvant endocrine therapy Phase III trials of new, paradigm-shifting clinical agents like topoisomerase When: December 10-14, 2008 Where: Henry B. Gonzales Convention Center San Antonio, TX CTRC-AACR Press Room: Location: Room 217 ...ESF EURYI award winner aims to stop cancer cells reading their own DNA
... much more specifically than traditional chemotherapy, avoiding side effects such as temporary hair loss. Dekker is focusing on an enzyme called topoisomerase IB that plays a key role in some of the molecular motors involved in the processes of DNA and RNA copying during cell division. These are responsible ...... featured on the cover of this issue. The enzyme topoisomerase IB releases the torsion built up in DNA strands. ... time as it acted on a single DNA molecule. The topoisomerase clamps onto the DNA, cuts through one of the two ... and under certain conditions even stop it. topoisomerase IB can reduce these torsional forces. The ...
Topoisomerase in Biological Technology
... Effects on Tubulin Polymerization and topoisomerase II",
reviewed results of a pharmacological ... of action -
inhibition of tubulin polymerization, topoisomerase activity as well as
antiangiogenic properties - ... to the AEZS-112 profile is the inhibition of topoisomerase I by compounds 2 and 3. Moreover, compound 2 ...
... compound, AEZS-126, as well as a poster on its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, at the American Association for Cancer ... outlines Phase 1 results for this orally-active tubulin and topoisomerase II inhibitor compound, in patients with advanced solid tumors and ...
... company focused on endocrine therapy and oncology, today presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the ...
... a treatment in a broad number of cancers; - SN2310 is a novel prodrug of SN-38, which is a potent anti-cancer drug belonging to the class of topoisomerase I inhibitors. SN2310 is designed to enhance the delivery and exposure of SN-38 to the tumor by providing greater prodrug conversion and a ...
... compound, AEZS-126, as well as a poster on its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, at the American Association for Cancer ... outlines Phase 1 results for this orally-active tubulin and topoisomerase II inhibitor compound, in patients with advanced solid tumors and ...
Sunesis Reports Financial Results for the Second Quarter 2009
... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...... company focused on endocrine therapy and oncology, today presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the ...
Sunesis Pharmaceuticals Reports Fourth Quarter and Full-Year 2008 Financial Results
... derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, G2 arrest and apoptosis. Voreloxin is currently being evaluated in a Phase 2 ...Sunesis Pharmaceuticals Provides Year-End Clinical Update on Voreloxin
... to quinolones, a class of compounds that has not been used previously for the treatment of cancer. Voreloxin both intercalates DNA and inhibits topoisomerase II, resulting in replication-dependent, site-selective DNA damage, irreversible G2 arrest and apoptosis. Voreloxin is currently being evaluated in a ...Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
... the molecular mechanisms of cancer. Focus lies on highly predictive cancer models and key cancer targets (including HDACi, NAD+, mTOR, FasLigand and topoisomerase II inhibitors). TopoTarget has a broad cllinical pipeline with 9 products in development, including belinostat which has shown proof of concept ...... a treatment in a broad number of cancers; - SN2310 is a novel prodrug of SN-38, which is a potent anti-cancer drug belonging to the class of topoisomerase I inhibitors. SN2310 is designed to enhance the delivery and exposure of SN-38 to the tumor by providing greater prodrug conversion and a ...
Poniard Pharmaceuticals Appoints Four New Members to Clinical Advisory Board
... on developing investigational agents and evaluating these compounds in Phase 1 and 2 clinical trials. He has published papers on taxanes and topoisomerase I inhibitors. He currently serves on the American Society of Clinical Oncology (ASCO) Board of Directors and is a member of ASCO's Ethics ...Sonus Pharmaceuticals and OncoGenex Technologies to Merge
... a treatment in a broad number of cancers; - SN2310 is a novel prodrug of SN-38, which is a potent anti-cancer drug belonging to the class of topoisomerase I inhibitors. It is currently in a Phase 1 trial and progress is being made to determine its safety and pharmacokinetic profile, in ...Topoisomerase in Biological Products
Human Topoisomerase II, Alpha from USB Corp.
Description:... Source: E. coli containing a clone of the human topoisomerase II gene. Description: topoisomerase II alters the topological state of nucleic acids ... catenate/decatenate or knot/unknot DNA molecules. topoisomerase II has an absolute requirement for divalent ...Company:USB Corp.
Human Topoisomerase II, Alpha from USB Corp.
Description:... Source: E. coli containing a clone of the human topoisomerase II gene. Description: topoisomerase II alters the topological state of nucleic acids ... catenate/decatenate or knot/unknot DNA molecules. topoisomerase II has an absolute requirement for divalent ...Company:USB Corp.
Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies
Description:... topoisomerase I from vaccinia virus is a type I eukaryotic topoisomerase that removes both positive and negative ... positive or negative superhelical turns. DNA topoisomerase I does not absolutely require Mg 2+ to function, ...Company:EPICENTRE Biotechnologies
Vaccinia DNA Topoisomerase I from EPICENTRE Biotechnologies
Description:... topoisomerase I from vaccinia virus is a type I eukaryotic topoisomerase that removes both positive and negative ... positive or negative superhelical turns. DNA topoisomerase I does not absolutely require Mg 2+ to function, ...Company:EPICENTRE Biotechnologies
Calf Topoisomerase I from USB Corp.
Description:... Source: Calf thymus Description: topoisomerase I relaxes both positively and negatively ... bonds (1,2) . Relaxing supercoiled DNA with topoisomerase I allows molecules to be differentiated by a single nucleotide pair by gel electrophoresis (3) . topoisomerase I is active in the absence of Mn 2+ and can be ...Company:USB Corp.
Human Topoisomerase I Wild Type from Calbiochem
Description:... µM EDTA, 20% glycerol, pH 7.9. AVOID FREEZE/THAW CYCLES. Human DNA topoisomerase I (Topo I) is a monomeric protein of 765 amino acids encoded by a ... energy. In addition to DNA replication and transcriptional activation, DNA topoisomerase I also plays a major role in pre-mRNA splicing, cell cycle and other gene ...Company:Calbiochem
HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot E. coli from Invitrogen
Description:... most effective technology available for cloning PCR products. TOPO TA Cloning and Zero Blunt TOPO vectors are supplied linearized and activated with topoisomerase I. This enables 5-minute, bench-top ligation and yields >=95% ...Company:Invitrogen
HTP Zero Blunt TOPO PCR Cloning Kit for Sequencing MultiShot StripWell E. coli from Invitrogen
Description:... most effective technology available for cloning PCR products. TOPO TA Cloning and Zero Blunt TOPO vectors are supplied linearized and activated with topoisomerase I. This enables 5-minute, bench-top ligation and yields >=95% ...Company:Invitrogen
Description:... high-efficiency (>=95%) cloning of blunt-end PCR products amplified with proofreading thermostable polymerases. The kit includes the linearized and topoisomerase I-activated pCR-Blunt II-TOPO vector for 5-minute bench-top ligations without ligase (1). The pCR-Blunt II-TOPO vector also ...
Company:Invitrogen
Description:... vector provides blunt ends for cloning PCR products amplified with proofreading thermostable polymerases. Each vector is supplied linearized and topoisomerase I-activated enabling 5-minute bench-top ligation yielding recombinants (1). Both vectors ...
Company:Invitrogen
Topoisomerase in Biological Dictionary
... topoisomerase I solves the problem caused by tension generated by winding/unwinding of DNA. ... See also topoisomerase inhibitor ... Eukaryotic type II topoisomerase cannot introduce supercoils; it ... In cancers, ...
... a second type IIA topoisomerase, ... Type I topoisomerase - Type II topoisomerase ( gyrase , topoisomerase IV) ... gyrase One of the type II ...
... a unique combination of a classical type I DNA topoisomerase ... DNA gyrase is distinct from all other ... DNA gyrase . ... DNA gyrase is a type II topoisomerase responsible for the manipulation of the ... ... supercoiling and re ... trapping of gyrase and topoisomerase IV on DNA probably ... gyrase removes ...
... Ribonucleotides located within the 4 bp cleavage stagger stimulate topoisomerase ... The positional effect of ribonucleotides on topoisomerase II-mediated cleavage ... Ribonucleotides are difficult to activate ...
... Cre recombinase , often abbreviated to Cre, is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of ... DNA inversion in the Salmonella ... Cre Recombinase is a Type I topoisomerase from bacteriophage P1 that catalyzes ... Is the Cre Recombinase ...
... If a DNA ... ... twisting it about the other strand, to relax DNA to a thermodynamic equilibrium. Once DNA is relaxed , topoisomerase reconnects broken strands. Structure ... ... with the amount of relaxed DNA to get you going and ... Relaxed , modified pBR-322 1000 ug ...
... the level of endoreduplication in epidermal cells ... Key words: Endoreduplication , gradient of gibberellic acid, lipid bodies, ... DNA topoisomerase VI Is Essential for Endoreduplication in Arabidopsis ... Endoreduplication is a common process in eukaryotes that involves DNA ... ... E ...
... a second type IIA topoisomerase, ... Type I topoisomerase - Type II topoisomerase ( gyrase , topoisomerase IV) ... gyrase One of the type II ...
... a unique combination of a classical type I DNA topoisomerase ... DNA gyrase is distinct from all other ... DNA gyrase . ... DNA gyrase is a type II topoisomerase responsible for the manipulation of the ... ... supercoiling and re ... trapping of gyrase and topoisomerase IV on DNA probably ... gyrase removes ...
... Ribonucleotides located within the 4 bp cleavage stagger stimulate topoisomerase ... The positional effect of ribonucleotides on topoisomerase II-mediated cleavage ... Ribonucleotides are difficult to activate ...
... Cre recombinase , often abbreviated to Cre, is a Type I topoisomerase from P1 bacteriophage that catalyzes site-specific recombination of ... DNA inversion in the Salmonella ... Cre Recombinase is a Type I topoisomerase from bacteriophage P1 that catalyzes ... Is the Cre Recombinase ...
... If a DNA ... ... twisting it about the other strand, to relax DNA to a thermodynamic equilibrium. Once DNA is relaxed , topoisomerase reconnects broken strands. Structure ... ... with the amount of relaxed DNA to get you going and ... Relaxed , modified pBR-322 1000 ug ...
... the level of endoreduplication in epidermal cells ... Key words: Endoreduplication , gradient of gibberellic acid, lipid bodies, ... DNA topoisomerase VI Is Essential for Endoreduplication in Arabidopsis ... Endoreduplication is a common process in eukaryotes that involves DNA ... ... E ...
Other ContentsOther TagsOther Tags
hyperglycemichyperhidrosishyperkalemiahyperinsulinismhypermobilehyperopiahyperparathyroidismhyperplasia
(Date:5/24/2013)... (PRWEB) May 24, 2013 HCG EZ Drops ... and is excited to announce it’s new weight loss initiative. “We ... we are offering our customers their money back if they don’t ... CEO of HCG EZ Drops. “The HCG Diet consists of ... the 21 pounds in 21 days.” , The controversial, cutting-edge diet ...
(Date:5/24/2013)... The leading retail brand Short Dresses ... prom dresses . Now that is quite unbelievable, especially in ... brand name since its origin. The retailer has already revealed ... this huge discount offer will be an added bonanza for ... privileged to announce that Short Dresses is to offer different ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Over the ... been gradually transforming, which has affected the Medical ... debt and seeking regular hours, more young physicians are ... or other medical groups,” says IBISWorld industry analyst Anna ... reimbursement pressure, a number of older physicians are selling ...
(Date:5/23/2013)... High blood glucose is associated with poor outcomes in ... to control hyperglycemia is a common practice in hospitals. ... benefit and even shows harms associated with the use ... (ACP) Clinical Guidelines Committee in a new evidence-based paper ... Medical Quality . , "Clinicians caring for hospitalized patients ...
(Date:5/23/2013)... 2013 The sodium theory ... and B. Katz in the early 1950s, after their ... of sodium and potassium ions in nerve functions ... acquisition techniques have known amazing developments. In The Sodium ... give an account of the latest developments in the ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 2Health News:Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries 3[0] HCG EZ Drops Announces 21 Pounds in 21 Days Money-Back Guarantee[0] short prom dresses Offers Abnormally Low Discount on Its New Collections[0] Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld[0] ACP issues recommendations for management of high blood glucose in hospitalized patients[0] Yves Pichon’s New Book Presents Latest Neurophysiological Discoveries
(Date:5/22/2013)... 22, 2013. Plastic additives known as phthalates (pronounced ... They turn up in flooring, plastic cups, beach ... Centers for Disease Control and Preventionthe bodies of ... come under increasing scrutiny. A growing collection of ... leech from packaging and mix with food) may ...
(Date:5/21/2013)... the nation,s land and water resources could likely support ... 25 billion gallons of algae-based fuel a year in ... , The findings come from an in-depth look at ... significant amounts of algae in large, specially built shallow ... issue of Environmental Science and Technology , published ...
(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4MU researchers develop radioactive nanoparticles that target cancer cells 2| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |